Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(1):11-12; doi:10.1093/jnci/93.1.11
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jones, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 1, 11-12, January 3, 2001
© 2001 Oxford University Press

NEWS

Tamoxifen Side Effects May Be Attributable to Other Causes

Jemarion Jones

For more than 20 years, the drug tamoxifen has been used to treat patients with advanced breast cancer and as adjuvant therapy following surgery or radiation therapy to treat early-stage breast cancer.

In spite of the obvious benefits of tamoxifen, there are a number of side effects that have been attributed to the drug, and these range from mild to life-threatening. Some of the less serious side effects include an increased risk of hot flashes, night sweats, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?